Reader-Supported · Editorially Reviewed
§ GLP-1 Weight Loss · The Listicle

Wegovy Cost Without Insurance in 2026: Telehealth Options Compared

Compare reviewed GLP-1 weight loss providers, billing commitments, and the treatments their links actually offer.

Last reviewed June 2026
2 studies cited
6 Reviewed PicksIndependent Review

We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology

Compare the options first

Full comparison & price terms ↓

A short preview in editorial order—not a guarantee of the cheapest total bill. Read the commitment terms before choosing.

$149/mo

Lower listed rate · not necessarily monthly billing

$129/mo

Lower listed rate · not necessarily monthly billing

Not sure which provider fits you? Take the 30-second quiz
Answer 4 quick questions to get a personalized provider match

The Ranking

6 reviewed picks
01
SkinnyRx logo

SkinnyRx

GLP-1 Weight LossFrom $99 – $199/mo
FDA-approved access
Best forCompounded and brand-name GLP-1 with overnight shipping

Clinician-guided GLP-1 platform with both compounded and brand-name access plus overnight shipping.

WegovyZepboundOzempicMounjarocompounded injectable tirzepatidecompounded injectable semaglutidecompounded oral tirzepatidecompounded sublingual semaglutideoral glp-1 pillsfoundayo (orforglipron)
Pros
All major brand-name GLP-1s available
Multiple administration routes per molecule
Cons
Higher entry price than entry-level competitors
Single-category, no men's, women's, or longevity adjuncts
Editor Score4.3
Cost
4.0
Experience
4.4
Trust
4.3
Start at SkinnyRxRead full review →

Editor’s take: Premium positioning, premium catalog. If you want maximum optionality across GLP-1 modalities, this is the deepest menu on the site. The premium catalog comes at a premium price. If you want maximum optionality across GLP-1 modalities, SkinnyRx is the deepest menu on the site; if you want the lowest cost, look at Trimi or HealthRx.

Full review →
02
Shed Rx logo

Shed Rx

GLP-1 Weight LossFrom $159 – $239/mo
FDA-approved access
Best forGLP-1 injections, oral semaglutide, and brand-name access

GLP-1 clinic offering injections, oral semaglutide, drops, and lozenges plus brand-name Wegovy and Zepbound.

WegovyZepboundcompounded semaglutidecompounded tirzepatideoral semaglutideoral glp-1 pillsglp-1 liquid dropsglp-1 lozenges
Pros
Multiple GLP-1 delivery formats
Brand-name Wegovy and Zepbound available
Cons
Limited state availability
Reports of auto-billing complaints
Editor Score4.2
Cost
4.2
Experience
4.2
Trust
4.0
Start at Shed RxRead full review →

Editor’s take: A reasonable mid-priced pick when delivery flexibility matters. Verify auto-billing terms before signing up given mixed reports. Verify auto-billing terms before signing up given mixed reviews on cancellation. If delivery flexibility is your priority, compare ShedRx against Breeze Meds which also offers sublingual tirzepatide.

Full review →
03
FuturHealth logo

FuturHealth

GLP-1 Weight LossFrom $198 – $395/mo
FDA-approved access
Best forGLP-1 paired with nutrition and fitness coaching

GLP-1 weight-loss platform combined with personalised nutrition and fitness coaching.

WegovyZepboundOzempicMounjarocompounded semaglutideoral glp-1 pills
Pros
Coaching layer included in the subscription
Wide brand-name GLP-1 access
Cons
Premium entry price
Coaching only matters if you actually use it
Editor Score4.0
Cost
3.7
Experience
4.4
Trust
4.2
Start at FuturHealthRead full review →

Editor’s take: Coaching is the differentiator. If you're going to use it, FuturHealth pulls ahead of cheaper, drug-only competitors. If you won't, save the money.

Full review →
Not sure which provider fits you? Take the 30-second quiz →
04
Found logo

Found

GLP-1 Weight LossFrom $129 – $349/mo
FDA-approved access
Best forGLP-1 paired with one-on-one coaching

GLP-1 platform that pairs medication with one-on-one coaching and a broad off-label formulary.

WegovyZepboundOzempicRybelsuscompounded semaglutidecompounded tirzepatidemetforminbupropiontopiramatenaltrexone
Pros
One-on-one coaching included
Broad medication formulary beyond GLP-1
Cons
Confusing multi-tier pricing
$99 early-cancellation fee
Editor Score4.2
Cost
4.0
Experience
4.3
Trust
4.2
Start Found GLP-1Read full review →

Editor’s take: One of the more coaching-forward GLP-1 telehealth options. Pricing tiers can confuse first-time buyers; verify the cancellation terms before subscribing. Pricing tiers can confuse first-time buyers; verify the cancellation policy before subscribing. If you want the lowest possible cost for compounded GLP-1 without coaching, Trimi or HealthRx will be significantly cheaper.

Full review →
05
Strut Health logo

Strut Health

Erectile DysfunctionFrom $149 – $399/mo
FDA-approved accessMulti-category
Best forMulti-category compounded telehealth for men

Broad-catalog telehealth covering hair, skin, weight loss, and sexual health, with free shipping and follow-ups bundled in.

WegovyZepboundOzempicMounjarocompounded semaglutide (oral & inj)compounded tirzepatide (oral & inj)oral glp-1 pillssermorelinsildenafiltadalafil+9 more
Pros
Wide formulary across categories, one provider for several concerns
Free shipping and follow-ups included in product pricing
Cons
No brand-name GLP-1 access
Generalist by design: less specialised than category-leaders
Editor Score4.6
Cost
4.4
Experience
4.5
Trust
4.4
Visit Strut HealthRead full review →

Editor’s take: An efficient generalist. If you want depth in any one category, you'll find better. If you want breadth and a low management overhead, Strut Health is on the shortlist.

Full review →
06
Zealthy logo

Zealthy

GLP-1 Weight LossFrom $25 – $151/mo
FDA-approved access
Best forInsurance navigation for GLP-1 care

Online GLP-1 care centered on insurance navigation, brand-name prescriptions and cash-pay semaglutide options.

WegovyZepboundOzempicMounjarosemaglutideWegovyZepboundOzempicMounjarocompounded GLP-1
Pros
Insurance-navigation support for brand-name GLP-1s
Cash-pay semaglutide option is publicly described
Cons
Lowest advertised price depends on insurance
Cash-pay semaglutide rate requires a three-month purchase
Editor Score4.0
Cost
3.8
Experience
4.1
Trust
4.0
Visit ZealthyRead full review →

Editor’s take: Zealthy pairs online weight-management care with insurance-navigation support and a cash-pay path. Its displayed $25–$151 monthly range is useful for comparison, but the endpoints carry different insurance and commitment conditions; confirm the exact medication, covered benefit, recurring fee, dose and renewal terms before paying.

Full review →
§ Price Comparison

2026 Price Comparison. Published Price Terms

Compare the lower and higher listed rates, then read the billing conditions. A listed monthly equivalent may require prepayment; visits, medication, membership, or shipping can cost extra.

Recorded price-check dates: 17 June 2026. Per-provider dates below; these are not a guarantee of today's checkout price.

Rates use different billing terms and are not necessarily all-in or month-to-month. Confirm total charges and cancellation terms. Compounded medications are not FDA-approved finished drugs; pharmacy type alone does not establish legality or clinical suitability.

2 providers · Trustpilot scores are customer opinions, not treatment results.

Provider & billing termsLower listed rateHigher listed ratePharmacyReviews & price checkActions
SkinnyRxBest ValueLower listed rate$149/moHigher listed rate$249/moPharmacyBrand Rx4.8/5

5,335 reviews

17 June 2026

Go SkinnyRxRead full review
Found HealthLower listed rate$129/moHigher listed rate$349/moPharmacyBrand Rx3.7/5

729 reviews

17 June 2026

Go FoundRead full review

Provider links may earn a commission. Rate sorting compares the displayed numbers, not equivalent treatment plans or total commitments. How we check price terms →

What to know before choosing

Wegovy (semaglutide 2.4 mg) has a retail list price of approximately $1,349-$1,700 per month in the United States without insurance. That price is not what most patients pay. Savings programmes, telehealth access fees, and compounded alternatives can significantly reduce the out-of-pocket cost. In the STEP 1 trial (NEJM 2021), participants lost a mean of 14.9% of body weight at 68 weeks, the clinical basis for the FDA approval. This guide breaks down every cost lever available in 2026.

Wegovy (semaglutide 2.4 mg) lists at approximately $1,349/month without insurance as of mid-2026. This is the manufacturer's list price — what you pay depends on your insurance coverage, whether you qualify for Novo Nordisk's savings programmes, and which pharmacy you use. Many patients pay significantly less than list price through manufacturer coupons, GoodRx, or telehealth platforms with negotiated pharmacy pricing.

Novo Nordisk's WeGoTogether savings programme offers Wegovy for as low as $0/month for eligible commercially insured patients and $499/month for uninsured patients who meet income criteria. GoodRx coupons can reduce the cash price to $900–$1,100/month at some pharmacies. Some telehealth platforms have negotiated below-list pricing through their pharmacy partnerships.

This guide covers every pricing pathway available for Wegovy without insurance, including manufacturer programmes, pharmacy pricing, and telehealth platform pricing. We update it monthly as pricing changes.

Methodology

Pricing data is sourced from telehealth provider websites and verified as of June 2026. Retail pharmacy prices are sourced from GoodRx and manufacturer pricing pages. Savings programme details are sourced from Novo Nordisk's official WeGoTogether programme page.

§ Long Read

Wegovy Without Insurance: How to Actually Afford It

Wegovy's list price of approximately $1,350/month is the number that appears in most media coverage — and it is not what most patients actually pay. Here is a complete breakdown of the real cost pathways.

Novo Nordisk's Savings Programs

Novo Nordisk offers WeGoSupport, a savings program that provides Wegovy at $0/month for commercially insured patients with coverage and $25/month for commercially insured patients whose plan does not cover Wegovy. The $25/month program has income eligibility requirements (household income below 400% of the federal poverty level).

For uninsured patients without income qualification, Novo Nordisk's patient assistance program (NovoCare) provides Wegovy at no cost to patients who meet income criteria (typically household income below 400% FPL). Applications are processed through the prescribing provider.

Compounded Semaglutide as a Cost Pathway

For patients who do not qualify for savings programs and cannot afford the list price, compounded semaglutide from a 503A or 503B pharmacy is the primary cost pathway — ranging from $150–$400/month depending on the clinic and pharmacy. The regulatory caveats discussed elsewhere in this guide apply.

The cost comparison: brand-name Wegovy at $25/month (with savings program) vs. compounded semaglutide at $150–$400/month makes brand-name the better value for qualifying patients. The savings program is underutilized because many patients and providers are not aware of it.

Insurance Navigation and Prior Authorization

Commercial insurance coverage for Wegovy has expanded significantly since 2023, particularly for patients with cardiovascular disease (following the SELECT trial). Many plans now cover Wegovy for patients with a BMI of 30+ and at least one comorbidity. Prior authorization is typically required.

Telehealth clinics that have dedicated insurance navigation support — helping patients with prior authorization appeals, documenting comorbidities, and identifying covered alternatives — are providing meaningful value beyond the prescription. The difference between a clinic that writes the prescription and one that helps you get it covered can be $1,300/month.

Wegovy is more affordable than the list price suggests for most patients — but accessing that affordability requires knowing which programs exist and how to apply. The clinics in our top tier above actively help patients navigate savings programs and insurance coverage.

§ Clinical Evidence

What the Studies Actually Show

Wegovy contains semaglutide 2.4 mg. The clinical evidence below is from the STEP 1 and SELECT trials, which form the basis of the FDA weight-management approval.

EndpointFinding
Mean weight loss (STEP 1, 68 weeks, 2.4 mg)1−14.9% body weight vs −2.4% placebo in adults with overweight/obesity without diabetes
Cardiovascular outcomes (SELECT, ~40 months)220% relative risk reduction in major adverse cardiovascular events (MACE) in adults with established CV disease and overweight/obesity
GI side effects (FDA prescribing information)3Nausea ≥10%, diarrhea ≥10%, vomiting ≥10%, constipation ≥10%; most cases mild–moderate and dose-dependent
§ FAQ

Frequently Asked Questions

What is the retail price of Wegovy without insurance?

The retail list price of Wegovy is approximately $1,349-$1,700 per month depending on dose and pharmacy. This is the price before any savings programmes, insurance, or telehealth access fees are applied.

How can I reduce the cost of Wegovy?

The main cost levers are: (1) Novo Nordisk's WeGoTogether savings card, which can reduce costs to $25-$200/month for eligible commercially insured patients; (2) insurance prior authorisation, which requires documentation of BMI 30 or higher, or 27 or higher with a comorbidity; (3) telehealth platforms that bundle the consultation fee with the prescription, reducing total access cost; (4) compounded semaglutide as a lower-cost alternative under the personalisation exception.

Is compounded semaglutide a cheaper alternative to Wegovy?

Yes. Compounded semaglutide from a 503A pharmacy typically costs $99-$299 per month. However, compounded products are not FDA-approved finished products, and the shortage exemption that previously allowed bulk compounding has ended. Compounding is still legal under the personalisation exception with a documented clinical justification.

References — Clinical Studies
  1. STEP 1 — NEJM 2021 · Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 2021;384:989–1002.
  2. SELECT — NEJM 2023 · Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med 2023;389:2221–2232.

RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.

§ Head-to-Head Comparisons

Compare Top Providers